Wilmer Cutler Pickering Hale and Dorr represented Nuvalent, Inc. in the offering, and Simpson Thacher & Bartlett represented the underwriters. Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Dyne Therapeutics, Inc. on the offering, and Cooley advised the underwriters. Dyne Therapeutics, Inc. (Nasdaq:DYN) announced the closing of...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Dyne Therapeutics, Inc., and Cooley advised the underwriters. Dyne Therapeutics, Inc. (Nasdaq:DYN) (“Dyne”) announced the closing of an underwritten public offering...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Inozyme Pharma and Shearman & Sterling represented the underwriters in the offering. Inozyme Pharma, Inc. announced the closing of its...
You must be a Standard 1 Year member to access this content.
